1
Back
J

Journal of Immunotherapy

IF2.9
Papers2136
Citations3215
Journal Papers 3520
Publication Date
delete
NUSAP1 Promotes Immunity and Apoptosis by the SHCBP1/JAK2/STAT3 Phosphorylation Pathway to Induce Dendritic Cell Generation in Hepatocellular Carcinoma (vol 48, pg 46, 2025)
deleteJournal of Immunotherapy
IF2.9
delete2026-04-01
delete0
PREAI
deleteChen, Guojie; Li, WenYa; Ge, Ruomu; Guo, Ting; Zhang, Yuhan; Zhou, Chenglin; Lin, Mei
deleteShare
deleteSave
Erratum: BCMA-targeting Bispecific Antibody That Simultaneously Stimulates NKG2D-enhanced Efficacy Against Multiple Myeloma
deleteJournal of Immunotherapy
IF2.9
delete2026-02-10
delete0
PREAI
deleteWang, Yang; Li, Hui; Xu, Wei; Pan, Mingzhu; Qiao, Chun; Cai, Jialing; Xu, Jingjing; Wang, Min; Zhang, Juan
deleteShare
deleteSave
Consequences of adverse events in cancer immunotherapy combinations – a comprehensive real-world analysis
deleteImmunotherapy
IF2.9
delete2025-12-10
delete0
PREAI
deleteSiv Gyda Aanes; Carsten Nieder; David Westfall Bates; Siri Wiig; Ellinor Christin Haukland
deleteShare
deleteSave
Plain language summary: treatment of Sjögren’s disease with dazodalibep
deleteImmunotherapy
IF2.9
delete2025-11-07
delete0
deleteOAAI
deleteE. William St. Clair; Alan N. Baer; Wan-Fai Ng; Ghaith Noaiseh; Teresa K. Tarrant; Athena Papas; Valerie Devauchelle-Pensec; Ilias Alevizos; Chiara Baldini
deleteShare
deleteSave
Remarkable response to anti-PD-L1 blockade in relapsed and refractory metastatic malignant giant cell tumor of bone: a case report
deleteImmunotherapy
IF2.9
delete2025-11-05
delete0
deleteOAAI
deleteJerry T. Wu; Jarrell Imamura; Elizabeth Nowak; Jessica Leng; John Reith; Scott Kilpatrick; Gary K. Schwartz; Zachary D. C. Burke
deleteShare
deleteSave
Simulating a virtual tumor board with large language models: a pilot study in NSCLC patients receiving immunotherapy
deleteImmunotherapy
IF2.9
delete2025-11-05
delete0
PREAI
deleteRashad Ismayilov; Ozden Altundag; Zafer Akcali
deleteShare
deleteSave
Development of eosinophilic esophagitis during wheat oral immunotherapy in children: a retrospective cohort analysis
deleteImmunotherapy
IF2.9
delete2025-11-02
delete0
PREAI
deleteAli Pourvali; Amin Tajerian; Maryam Zamanian; Javad Nazari; Mohammad Nabavi; Mohammad Hasan Bemanian; Morteza Fallahpour
deleteShare
deleteSave
Effects of serotonergic drugs on immune checkpoint inhibitor response: a pooled analysis of individual patient data from four Canadian Cancer Trials Group (CCTG) trials
deleteImmunotherapy
IF2.9
delete2025-11-01
delete0
PREAI
deleteCourtney H Coschi; Keyue Ding; Dongsheng Tu; Christopher O’Callaghan; Natasha B Leighl; Francisco Vera-Badillo; Rosalyn A Juergens; Desiree Hao; Lesley Seymour; Daniel J Renouf; Eric Chen; Andrea S Fung; Pierre-Olivier Gaudreau
deleteShare
deleteSave
Plain language summary of disease activity and therapeutic response to pegcetacoplan for geographic atrophy identified by deep learning-based analysis of OCT
deleteImmunotherapy
IF2.9
delete2025-10-24
delete0
deleteOAAI
deleteUrsula Schmidt-Erfurth; Julia Mai; Gregor S. Reiter; Sophie Riedl; Wolf-Dieter Vogl; Amir Sadeghipour; Alex McKeown; Emma Foos; Lukas Scheibler; Hrvoje Bogunovic
deleteShare
deleteSave
The potential of CAR T cells in autoimmune diseases
deleteImmunotherapy
IF2.9
delete2025-10-23
delete0
PREAI
deleteJohanna Richter; Martin Krusche; Isabell Haase; Ina Kötter; Nicolaus Kröger
deleteShare
deleteSave
5-year real-world outcomes with first-line pembrolizumab plus chemotherapy in advanced/metastatic NSCLC
deleteImmunotherapy
IF2.9
delete2025-10-17
delete0
PREAI
deleteStephen V. Liu; Riddhi A. Babel; Yu-Han Kao; Diana Chirovsky; Azadeh Namakydoust; Vamsidhar Velcheti
deleteShare
deleteSave
How should we choose optimal salvage treatments following BCMA-directed CAR T-cell therapy?
deleteImmunotherapy
IF2.9
delete2025-10-17
delete0
deleteOAAI
deleteArvind Suresh; Darren Pan; Jodi Lipof; Anupama Kumar; Shagun Arora; Peter Sayre; Jeffrey Wolf; Thomas Martin; Ajai Chari; Alfred Chung
deleteShare
deleteSave
Cost-utility analysis of blinatumomab in pediatric patients with acute lymphoblastic leukemia in Iran
deleteImmunotherapy
IF2.9
delete2025-10-15
delete0
PREAI
deleteGolara Nikakhtar; Zahra Amiri; Aziz Eghbali; Behzad Fatemi
deleteShare
deleteSave
Recombinant GM-CSF drug evaluation review
deleteImmunotherapy
IF2.9
delete2025-10-14
delete0
PREAI
deleteJack McCarthy; Niamh Boyle; Cormac McCarthy
deleteShare
deleteSave
Allogeneic CAR-T cell therapy in autoimmune diseases
deleteImmunotherapy
IF2.9
delete2025-10-14
delete0
PREAI
deleteYuanyuan Ma; Juliang Qin; Mingyao Liu; Bing Du
deleteShare
deleteSave
Evaluating the efficacy and safety of tezepelumab in the treatment of chronic rhinosinusitis with nasal polyps
deleteImmunotherapy
IF2.9
delete2025-10-14
delete0
PREAI
deleteJennifer Priessnitz; Jaekeun Jung; Joseph K. Han; Kent K. Lam
deleteShare
deleteSave
Exploring new treatment strategies for hard-to-treat double-hit and double-expressor lymphomas
deleteImmunotherapy
IF2.9
delete2025-10-13
delete0
deleteOAAI
deleteMax F. Kelsten; Reem Karmali
deleteShare
deleteSave
Diagnostic and therapeutic evaluation of Blomia tropicalis in patients with allergic rhinitis
deleteImmunotherapy
IF2.9
delete2025-10-12
delete0
PREAI
deleteAna Caraballo; Laura Osorio; Susana Díez; Carlos Chinchilla; Leidy Álvarez; Luis Caraballo; Jorge Sánchez
deleteShare
deleteSave
Durable response to an anti-CD25 antibody-drug conjugate and anti-PD-1 antibody in ovarian carcinoma: a case report
deleteImmunotherapy
IF2.9
delete2025-09-19
delete0
PREAI
deleteFaraah Bekheet; Melanie Ashland; Rochelle Reyes; Oliver Dorigo; Amer Karam; Christopher T. Chen
deleteShare
deleteSave
The potential of phytomedicines to optimize CAR-T cell therapy in cancer
deleteImmunotherapy
IF2.9
delete2025-09-19
delete0
PREAI
deleteÁngela Covo-Vergara; Uxue Díez De ulzurrun-Ripa; Cristian Smerdou; Mercedes Hernández-Rueda; Delia G. Estrada-Palafox; Claudia Ureña; Sandra Hervas-Stubbs; Susana Fiorentino; Maritza R. Garcia-Garcia
deleteShare
deleteSave